the staff of the Ridgewood blog
New Brunswick NJ, At Johnson & Johnson has temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant. The participant’s illness is being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board (DSMB) as well as our internal clinical and safety physicians.
Continue reading Johnson & Johnson Temporarily Pauses COVID-19 Vaccine Candidate Clinical Trial
